" class="no-js "lang="en-US"> Financing Archives - Medtech Alert
Saturday, December 09, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment

SciTech Development has announced it has closed a $2.73M funding round, led by several prominent […]

RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications

RxLightning, creator of the industry’s first comprehensive platform for streamlining specialty medication access and affordability, […]

Cytovation Raises $8 Million in Series A Extension Financing Round for Clinical Advancement of CyPep-1, a First-in-class Targeted Tumor Membrane Immunotherapy

Cytovation ASA, a clinical-stage immune-oncology company focused on the development of its first-in-class targeted tumor […]

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close […]

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases

Ray Therapeutics, a leading optogenetics company, today announced an upsized and oversubscribed $100M Series A […]

DiogenX Raises €27.5M Series A Financing to Advance its First-In-Class Treatment for Type 1 Diabetes

DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, […]

Solarea Bio Announces First Close of Series B Financing Round

Solarea Bio, a clinical-stage biotechnology company based in Cambridge, MA developing food-derived microbial-based solutions to […]

Antiva Biosciences Closes $53 Million Series E Equity Financing

Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions […]

Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases

Therini Bio, a biotech company aimed at developing fibrin-targeted therapies to treat inflammatory neurodegenerative and […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more